Evidence map›Paper›PMID 28674053›Full record

ArticleAntimicrobial agents and chemotherapy2017

Dale M Mazer, Carol Young, Linda M Kalikin, Theodore Spilker, John J LiPuma

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.2field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. In vitro susceptibility ofNew microbes and new infections · 2025
    Review
  3. Article
  4. Review
  5. Article
  6. Clinical microbiology reviews · 2020
    Review
  7. Antimicrobial agents and chemotherapy · 2018
    Article
  8. Article
  9. Antimicrobial agents and chemotherapy · 2018
    Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Dale M MazerDepartment of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA.
Carol YoungDepartment of Pathology, University of Michigan Medical School, Ann Arbor, Michigan, USA.
Linda M KalikinDepartment of Pediatrics and Communicable Diseases, University of Michigan Medical School, Ann Arbor, Michigan, USA.
Theodore SpilkerDepartment of Pediatrics and Communicable Diseases, University of Michigan Medical School, Ann Arbor, Michigan, USA.
John J LiPumaDepartment of Pediatrics and Communicable Diseases, University of Michigan Medical School, Ann Arbor, Michigan, USA jlipuma@umich.edu.
University of Michigan–Ann Arbor · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We tested the activities of ceftolozane-tazobactam and 13 other antimicrobial agents against 221 strains of

Indexed as

Anti-Bacterial Agentsbeta-Lactamase InhibitorsBurkholderia cepacia complexBurkholderia gladioliBurkholderia InfectionsCephalosporinsCystic FibrosisDrug CombinationsHumansMicrobial Sensitivity TestsPenicillanic AcidTazobactamAnti-Bacterial Agentsbeta-Lactamase Inhibitorsceftolozane, tazobactam drug combinationCephalosporinsDrug CombinationsPenicillanic AcidTazobactamBurkholderiaceftolozanecystic fibrosis

Identifiers

PMID28674053
PMCPMC5571321
OpenAlexW2731847799

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.